General Information
Revision date
2023-01-10
Product name
Linezolid for Oral suspension 100 mg/5 mL
CAS No.
165800-03-3
1.2.1 Relevant identified uses
Pharmaceutical product
Manufacturer Name
Annora Pharma Private Limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc.
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS - Classification Not classified as hazardous
Physical hazards
Combustible Dust EU Classification EU Indication of danger Not classified
Hazard statements
May form combustible dust concentrations in air
2.3 Other hazards
No data available Australian Hazard Non-Hazardous Substance. Non-Dangerous Goods. Classification (NOHSC) Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace
2.1 Classification of the substance or mixture
GHS - Classification Not classified as hazardous Physical Hazard Combustible Dust EU Classification: EU Indication of danger Not classified